Johnson & Johnson Reports Strong Q2, Solid Growth in Vision Care
NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ), a global healthcare company, announced its second-quarter 2026 financial results yesterday, reporting a 6.6 percent increase in sales to $25.3 billion.…





![“If I have any problems, I just want to see my [primary care] doctor”: perspectives on a proposed collaborative RUral PALliative care intervention (RuPal) | BMC Palliative Care](https://www.healthmkts.com/wp-content/uploads/2026/07/If-I-have-any-problems-I-just-want-to-see-824x620.png)



